Effects of the P2-purinoceptor antagonist, suramin, on human platelet aggregation induced by adenosine 5'-diphosphate.

Eitemau Tebyg

• Specific but noncompetitive inhibition by 2-alkylthio analogues of adenosine 5'-monophosphate and adenosine 5'-triphosphate of human platelet aggregation induced by adenosine 5'-diphosphate.
  gan: Cusack, N. J., et al.
  Cyhoeddwyd: (1982)
• Adenosine 5-diphosphate antagonists and human platelets: no evidence that aggregation and inhibition of stimulated adenylate cyclase are mediated by different receptors.
  gan: Cusack, N. J., et al.
  Cyhoeddwyd: (1982)
• Differential effects of adenine nucleotide analogues on shape change and aggregation induced by adenosine 5′-diphosphate (ADP) in human platelets
  gan: Park, Hye-Seong, et al.
  Cyhoeddwyd: (1999)
• Competitive inhibition by adenosine 5'-triphosphate of the actions on human platelets of 2-chloroadenosine 5'-diphosphate, 2-azidoadenosine 5'-diphosphate and 2-methylthioadenosine 5'-diphosphate.
  gan: Cusack, N. J., et al.
  Cyhoeddwyd: (1982)
• The role of adenosine diphosphate (ADP) in collagne-induced platelet aggregation.
  gan: Nunn, B
  Cyhoeddwyd: (1972)